Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

20.6x

EV/EBITDA

10.1x

Market Cap

HKD 42.75B

MomentumView details →

1D Return

+0.37%

YTD Return

−17.14%

RSI (14)

45.5

ValuationView details →

P/E (Fwd)

20.6x

EV/EBITDA

10.1x

Market Cap

HKD 42.75B

RSI (14)

45.5

MomentumView details →

1D Return

+0.37%

YTD Return

−17.14%

ProfitabilityView details →

Gross Margin

50.13%

Net Margin

8.15%

EBITDA Margin

12.00%

ROE (TTM)

10.33%

ROA (TTM)

4.01%

Asset Turnover

0.50x

GrowthView details →

Revenue YoY

+53.92%

EPS YoY

+57.02%

FCF YoY

+191.31%

Revenue CAGR 3Y

−2.75%

EPS CAGR 3Y

−4.64%

EBITDA YoY

+16.99%

EarningsView details →

EPS (Actual)

HKD 0.75

EPS Surprise

111.55%

Beats (12Q)

1/12

Next Q EPS Est

HKD 0.35

Avg Surprise (4Q)

111.55%

Rev Surprise

96.67%

Capital & dividendView details →

Debt/Equity

0.81x

Current Ratio

0.90x

Quick Ratio

0.75x

Div Yield

2.78%

Div Rate

HKD 0.45

Div Growth 1Y

+28.57%

Financials snapshotView financials →

Revenue (TTM)

61.75B

Net Income (TTM)

5.03B

Op. CF (TTM)

5.50B

Next earningsMar 29, 2027 →

Latest newsMore news →

Fosun High Technology, the controlling shareholder of Fosun Pharma, pledged 330 million A-shares to ICBC Shanghai Changning Sub-branch on September 3, 2026, to secure debt repayment.10h ago

Fosun Pharma launched a block deal to divest 5% equity in Gland Pharma worth Rs 2,279 crore at a floor price of Rs 2,763 per share.1d ago

Similar companies

Teva Pharmaceutical Industries LimitedTEVA MYUNGMOON Pharm co.,Ltd017180.KS Haleon plcHLN 白云山600332.SH Yuyu Pharma, Inc.000225.KS Zoetis Inc.ZTS Find similar companies →

Latest newsMore news →

Fosun High Technology, the controlling shareholder of Fosun Pharma, pledged 330 million A-shares to ICBC Shanghai Changning Sub-branch on September 3, 2026, to secure debt repayment.10h ago Fosun Pharma launched a block deal to divest 5% equity in Gland Pharma worth Rs 2,279 crore at a floor price of Rs 2,763 per share.1d ago Fosun Pharma's controlling shareholder Fosun High Technology released a pledge on 69 million A-shares on July 21, 2026, and disclosed a subsequent pledge plan.44d ago